DGAP-News: GANÉ Aktiengesellschaft : ACATIS GANÉ Value

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 15, 2016 at 8:15 AM

DGAP-News: GANÉ Aktiengesellschaft : ACATIS GANÉ Value Event fund wins Morningstar Award in France and Austria

DGAP-News: GANÉ Aktiengesellschaft / Key word(s): Funds GANÉ Aktiengesellschaft : ACATIS GANÉ Value Event fund wins Morningstar Award in France and Austria 15.04.2016 / 14:00 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Press release ACATIS GANÉ Value Event fund wins Morningstar Award in France and Austria Aschaffenburg, 15 April 2016 - The mixed asset management fund set up by GANÉ Aktiengesellschaft, which was launched in 2008 in close cooperation with ACATIS Investment GmbH, collected the prestigious 2016 Morningstar Award in France and Austria in the category "Best EUR Allocation Fund". The awards were presented in Paris on February 16 and in Vienna on April 12. The Morningstar Award honors funds and fund groups which, after risk adjustment, provide the best outperformance. The method looks at the risk-adjusted returns over one-, three- and five-year periods. Thomas Lancereau, Morningstar fund analyst: "All of our winners delivered strong three- and five-year returns after adjusting for risk, in addition to outperformance of their peers during the last 12 months. These funds and fund houses have demonstrated that they have the ability to earn strong returns over the long-term without undue risk. We believe that taking a patient, long-term view to investing will ultimately help investors reach their financial goals.ˮ The ACATIS GANÉ Value Event fund has achieved an increase of 121% since it was set up. Measured against the period of time, this corresponds to an average return of 11% per year. The fund volume amounts to EUR 1.226 million (as of 14/04/2016). In the process, the asset-management mixed fund showed average volatility of only 8% and significantly reduced periods of losses over the entire term. The value and event strategy was established by GANÉ Aktiengesellschaft. On the basis of a variable investment ratio in shares, bonds and liquid assets, it is hoped to achieve returns which are similar to those from shares and to ensure the volatility remains at a low level. <pre> Management Universal-Investment-Gesellschaft mbH company Custodian Hauck&Aufhäuser Privatbankiers KGaA bank Team Universal-Investment (manager), ACATIS (advisor), GANÉ (sub- advisor) ISIN Share class A: DE000A0X7541 Share class B: DE000AIC5DI3 Share class C: DE000AIT73W9 Fund volume EUR 1.226 million Minimum None investment Running Share class A: 1.79% costs Share class B: 1.41% Share class C: 1.79% Subscript- Share class A and C: up to 5% ion fee Share class B: up to 4% Performan- 20% of the performance exceeding 6% p.a., in the event of a new ce fee share value high (share class B: maximum 2% p.a.) </pre> - END - You can find detailed information at www.gane.de <pre> Contact: Press contact: GANÉ Aktiengesellschaft KERL und CIE Dr Uwe Rathausky David Kerl J. Henrik Muhle E-mail: d.kerl@kerlundcie.de E-mail: kontakt@gane.de Tel.: +49 (0)69 870 021 50 Weißenburger Straße 36 Hamburger Allee 45 63739 Aschaffenburg 60486 Frankfurt am Main Headquarters: Aschaffenburg Commercial court: Aschaffenburg HRB 10188 Management: Dr Uwe Rathausky, J. Henrik Muhle Chairman of the Supervisory Board: Achim Josefy </pre> --------------------------------------------------------------------------- 15.04.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- 454631 15.04.2016

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Busch Gardens' Holiday Extravaganza Lights Up 2026

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

Concurrence Expands Reach With Microsoft Marketplace

Concurrence's Big Move into Microsoft's Court From the bustling streets of New York to the mighty tech avenues of Seattle, Concurrence is making waves that could leave a whale-sized impact on the healthcare sector. As of today, their Health World Model and snazzy AI agents have entered the Microsoft Marketplace, marking a significant leap forward. For the uninitiated,...

Reducto Office Transforms Document Editing with AI

AI Meets Full-Fidelity Document Editing Gone are the days when AI could only analyze documents. With Reducto Office's latest plugin, the AI's stepping right into the editing game. For free, they say! Built smack-dab into ChatGPT and Codex, this plugin lets users work their AI magic on Word docs, PowerPoint presentations, and Excel spreadsheets. And the kicker? You can see...

Entangled 2026 Summit: Driving Quantum, AI, & Biotech Synergy

What's Brewing at Entangled 2026? Innovation's got a new haunt come November, and it’s sprouting right in Cambridge's Kendall Square. LabCentral, C10 Labs, and Innovation Centre Denmark Boston have concocted something here for the curious minds: Entangled 2026. Picture over 250 movers and shakers from biotech, deep tech, investment, academia, and more, gathering under...

Celebrate Dr. David Neff's Healthcare Legacy

By Lucas Young Updated Oct 28, 2026 Category News Views 107

An Icon in Medicine and Innovation Dr. David R. Neff's recognition as a Pinnacle Lifetime Member marks a storied journey through medicine and healthcare innovation. Decades of Dedication to Patient Care For over 45 years, Neff carved out a niche in medicine that few can parallel. His overarching focus on infectious disease, cancer, and more represents a holistic approach...

Arctic Wolf Leads in AI SOC: A 2026 Game Changer

Leading the Pack with AI-Powered Security In the world of cybersecurity, where every day feels like a battlefield, Arctic Wolf has clawed its way to the top spot in the Q4 2026 QKS SPARK Matrix™ for AI SOC Automation. This recognition doesn't just highlight their prowess in handling security operations; it underscores their relentless commitment to infusing AI...

Pozdeutinurad Phase 3 Success Impact on Sobi and Market

Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...

xTool X1: Redefining Laser Fabrication for Makers

The Next Generation of Laser Fabrication Whenever a new gizmo hits the market, it's usually just an upgrade in disguise—faster, shinier, a touch more wattage. Not this time. xTool shook things up by rolling out the X1, a laser platform that gets what small businesses and makers truly crave: versatility and long-lasting potential. This bad boy does more than engrave; it...

Tiny Fish Revolutionizes Vertebrate Gene Studies

From Small Fish to Big Discoveries: Meet Danionella cerebrum Who would've thought a diminutive fish with a see-through body would give a jolt to the study of vertebrate genomes? Thanks to Danionella cerebrum, researchers at the Whitehead Institute have created the very first complete whole-body single-cell atlas of an adult vertebrate. Forget the Wall Street clamor for a...

A. O. Smith Reports Q3 2026: A Strategic Shift

A. O. Smith Navigates Change in Third Quarter 2026 It's been a gritty third quarter for A. O. Smith, as the company maneuvers through domestic challenges and crafts a strategic future with international tweaks. They've hammered out $941 million in sales but found themselves grappling with net earnings dipping to $126 million, or $0.93 per diluted share, a mere blip from...